For the second time in recent months, a U.K. agency said the limited benefits of a new Alzheimer’s drug do not justify its ...

Congress is facing a slew of expiring Medicare policies, and the end of Trump's tax cuts and Biden's extra ACA subsidies.

While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...

Health policy scholar Paul Ginsburg joins the "First Opinion Podcast" to discus Medicare policy and the election.

Mark Cuban is a man on a mission — to disrupt the pharmaceutical industry.

New research calls into question the high-profile conclusion of the first major study to show a physician's race influences ...

Linda Barbour thought she was more interested in the Change Healthcare cyberattack than most. Having worked as a medical ...

AvenCell Therapeutics announced that it raised $115 million in a Series B round. The company is developing CAR-T therapies ...

The agency posted documents this week that the drugmaker had requested the drug be placed on the FDA's "Demonstrable ...

A new study shows that Americans are more supportive than ever of a robust drug-epidemic response and access to addiction ...

Michelle Tarver will be the new leader of the medical devices center at the Food and Drug Administration, according to an ...

HLTH 2024 features high-profile panels, offline conversations, and chatter on buzzy topics like GLP-1 and health AI.